Recombinant multi-species NR1I3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NR1I3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the nuclear receptor superfamily, and is a key regulator of xenobiotic and endobiotic metabolism. The protein binds to DNA as a monomer or a heterodimer with the retinoid X receptor and regulates the transcription of target genes involved in drug metabolism and bilirubin clearance, such as cytochrome P450 family members. Unlike most nuclear receptors, this transcriptional regulator is constitutively active in the absence of ligand but is regulated by both agonists and inverse agonists. Ligand binding results in translocation of this protein to the nucleus, where it activates or represses target gene transcription. These ligands include bilirubin, a variety of foreign compounds, steroid hormones, and prescription drugs. In addition to drug metabolism, the CAR protein is also reported to regulate genes involved in glucose metabolism, lipid metabolism, cell proliferation, and circadian clock regulation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2020]
The Alternative Names of target: CAR,CAR-beta,CAR1,Care2,Constitutive activator of retinoid response (Constitutive active response),Constitutive androstane receptor (CAR),ESTM32,MB67,NR1I3,Nr1i3,Nuclear receptor subfamily 1 group I member 3,Orphan nuclear receptor MB67
Go
to NR1I3 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T69506-Ag-1/ GM-Tg-hg-T69506-Ag-2 | Human NR1I3 protein | Human |
| GM-Tg-rg-T69506-Ag-1/ GM-Tg-rg-T69506-Ag-2 | Rat NR1I3 protein | Rat |
| GM-Tg-mg-T69506-Ag-1/ GM-Tg-mg-T69506-Ag-2 | Mouse NR1I3 protein | Mouse |
| GM-Tg-cynog-T69506-Ag-1/ GM-Tg-cynog-T69506-Ag-2 | Cynomolgus/Rhesus macaque NR1I3 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T69506-Ag-1/ GM-Tg-felg-T69506-Ag-2 | Feline NR1I3 protein | Feline |
| GM-Tg-cang-T69506-Ag-1/ GM-Tg-cang-T69506-Ag-2 | Canine NR1I3 protein | Canine |
| GM-Tg-bovg-T69506-Ag-1/ GM-Tg-bovg-T69506-Ag-2 | Bovine NR1I3 protein | Bovine |
| GM-Tg-equg-T69506-Ag-1/ GM-Tg-equg-T69506-Ag-2 | Equine NR1I3 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T69506-Ag-1/ GM-Tg-hg-T69506-Ag-2;
GM-Tg-rg-T69506-Ag-1/ GM-Tg-rg-T69506-Ag-2;
GM-Tg-mg-T69506-Ag-1/ GM-Tg-mg-T69506-Ag-2; GM-Tg-cynog-T69506-Ag-1/ GM-Tg-cynog-T69506-Ag-2; GM-Tg-felg-T69506-Ag-1/ GM-Tg-felg-T69506-Ag-2; GM-Tg-cang-T69506-Ag-1/ GM-Tg-cang-T69506-Ag-2; GM-Tg-bovg-T69506-Ag-1/ GM-Tg-bovg-T69506-Ag-2; GM-Tg-equg-T69506-Ag-1/ GM-Tg-equg-T69506-Ag-2 |
| Products Name | NR1I3 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | NR1I3 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NR1I3 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.